152 related articles for article (PubMed ID: 27227290)
1. Duration of Infusion Set Survival in Lipohypertrophy Versus Nonlipohypertrophied Tissue in Patients with Type 1 Diabetes.
Karlin AW; Ly TT; Pyle L; Forlenza GP; Messer L; Wadwa RP; DeSalvo DJ; Payne SL; Hanes S; Clinton P; Maahs DM; Buckingham B
Diabetes Technol Ther; 2016 Jul; 18(7):429-35. PubMed ID: 27227290
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial of infusion set function: steel versus teflon.
Patel PJ; Benasi K; Ferrari G; Evans MG; Shanmugham S; Wilson DM; Buckingham BA
Diabetes Technol Ther; 2014 Jan; 16(1):15-9. PubMed ID: 24090124
[TBL] [Abstract][Full Text] [Related]
3. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3.
Schmid V; Hohberg C; Borchert M; Forst T; Pfützner A
J Diabetes Sci Technol; 2010 Jul; 4(4):976-82. PubMed ID: 20663464
[TBL] [Abstract][Full Text] [Related]
4. A web-based study of the relationship of duration of insulin pump infusion set use and fasting blood glucose level in adults with type 1 diabetes.
Sampson Perrin AJ; Guzzetta RC; Miller KM; Foster NC; Lee A; Lee JM; Block JM; Beck RW;
Diabetes Technol Ther; 2015 May; 17(5):307-10. PubMed ID: 25622214
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart.
Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM
J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891
[TBL] [Abstract][Full Text] [Related]
6. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
Hernar I; Haltbakk J; Broström A
J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
[TBL] [Abstract][Full Text] [Related]
7. Insulin Pump Infusion Set Failures Associated with Prolonged Hyperglycemia: Frequency and Relationship to Age and Type of Infusion Set During 22,741 Infusion Set Wears.
Kanapka LG; Lum JW; Beck RW
Diabetes Technol Ther; 2022 Jun; 24(6):396-402. PubMed ID: 35104166
[No Abstract] [Full Text] [Related]
8. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
9. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
10. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
[TBL] [Abstract][Full Text] [Related]
11. Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.
Bode BW; Johnson JA; Hyveled L; Tamer SC; Demissie M
Diabetes Technol Ther; 2017 Jan; 19(1):25-33. PubMed ID: 28055230
[TBL] [Abstract][Full Text] [Related]
12. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
13. Effects of performing morning versus afternoon exercise on glycemic control and hypoglycemia frequency in type 1 diabetes patients on sensor-augmented insulin pump therapy.
Gomez AM; Gomez C; Aschner P; Veloza A; Muñoz O; Rubio C; Vallejo S
J Diabetes Sci Technol; 2015 May; 9(3):619-24. PubMed ID: 25555390
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of real-time continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial.
Tumminia A; Crimi S; Sciacca L; Buscema M; Frittitta L; Squatrito S; Vigneri R; Tomaselli L
Diabetes Metab Res Rev; 2015 Jan; 31(1):61-8. PubMed ID: 24816997
[TBL] [Abstract][Full Text] [Related]
15. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
[TBL] [Abstract][Full Text] [Related]
16. Insulin Infusion Set Use: European Perspectives and Recommendations.
Deiss D; Adolfsson P; Alkemade-van Zomeren M; Bolli GB; Charpentier G; Cobelli C; Danne T; Girelli A; Mueller H; Verderese CA; Renard E
Diabetes Technol Ther; 2016 Sep; 18(9):517-24. PubMed ID: 27526329
[TBL] [Abstract][Full Text] [Related]
17. Longevity of the novel ConvaTec infusion set with Lantern technology.
Lal RA; Hsu L; Zhang J; Schøndorff PK; Heschel M; Buckingham B
Diabetes Obes Metab; 2021 Aug; 23(8):1973-1977. PubMed ID: 33822472
[TBL] [Abstract][Full Text] [Related]
18. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
19. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.
Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW
JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010
[TBL] [Abstract][Full Text] [Related]
20. Multinight "bedside" closed-loop control for patients with type 1 diabetes.
Brown SA; Kovatchev BP; Breton MD; Anderson SM; Keith-Hynes P; Patek SD; Jiang B; Ben Brahim N; Vereshchetin P; Bruttomesso D; Avogaro A; Del Favero S; Boscari F; Galasso S; Visentin R; Monaro M; Cobelli C
Diabetes Technol Ther; 2015 Mar; 17(3):203-9. PubMed ID: 25594434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
